May 2025

Cobenfy Stands Out in 2024 Against Schizophrenia: A Breakthrough in Mental Health Treatment

Schizophrenia, a chronic and severe mental health disorder, affects approximately 1 in 100 people worldwide. Characterized by symptoms such as hallucinations, delusions, disorganized thinking, and emotional blunting, schizophrenia presents significant challenges both for patients and healthcare systems. Traditionally, antipsychotic medications have been the cornerstone of treatment, but many individuals continue to struggle with side effects …

Cobenfy Stands Out in 2024 Against Schizophrenia: A Breakthrough in Mental Health Treatment Read More »

Alhemo: 2024 presents a solution to Hemophilia

Hemophilia is a rare but serious genetic disorder that impairs the blood’s ability to clot, leading to prolonged bleeding and frequent hemarthroses (joint bleeds). For individuals living with this condition, managing bleeding episodes is paramount to preventing complications such as joint damage and long-term disability. Over the past few years, new treatments have emerged to …

Alhemo: 2024 presents a solution to Hemophilia Read More »

Advances in Clinical Research for Migraines

From Pills to Circuits:  How Clinical Trials are pushing the frontier of migraine treatment Migraines are more than just headaches. They are complex neurological conditions that affect over one billion people worldwide, characterized by intense, throbbing pain, often accompanied by symptoms like nausea, sensitivity to light and sound, and visual disturbances. While the exact mechanisms …

Advances in Clinical Research for Migraines Read More »